Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.80+0.00 (0.00%)
Close on Nov 17, 2026Market cap $935.48MP/E –Yield –
Silence Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Silence Therapeutics's price to sales ratio was 388.5× on May 29, 2026, against 4.0× a year earlier. Over the last 3 years it ranged from 3.1× to 459.7×, with a median of 12.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | May 29, 2026 | 388.5× | +377.3 |
| 2025 | Dec 31, 2025 | 11.1× | +2.5 |
| 2024 | Dec 31, 2024 | 8.6× | −20.2 |
| 2023 | Dec 29, 2023 | 28.8× | – |
See a number that looks wrong?